Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,775,773 |
|
|||||
| News | (1) | ||||||
| Day High | 28.19 | Low High |
|||||
| Day Low | 27.69 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Royalty Pharma PLC | RPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.27 | 0.97% | 28.16 | 17:13:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.85 | 27.69 | 28.19 | 28.16 | 27.89 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 23,839 | 1,775,773 | $ 27.95 | $ 49,629,805 | - | 25.92 - 36.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:07:19 | 4 | $ 28.75 | USD |
Royalty Pharma PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.82B | 597.43M | - | 2.35B | 1.13B | 1.90 | 14.82 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Royalty Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.06 | 29.06 | 27.425 | 27.92 | 2,416,249 | -0.90 | -3.10% |
| 1 Month | 30.58 | 30.80 | 27.425 | 29.07 | 2,336,188 | -2.42 | -7.91% |
| 3 Months | 29.27 | 31.655 | 27.35 | 29.68 | 2,767,939 | -1.11 | -3.79% |
| 6 Months | 27.44 | 31.655 | 26.07 | 28.75 | 2,543,429 | 0.72 | 2.62% |
| 1 Year | 35.71 | 36.48 | 25.92 | 29.70 | 2,411,913 | -7.55 | -21.14% |
| 3 Years | 41.97 | 47.10 | 25.92 | 36.23 | 2,104,168 | -13.81 | -32.90% |
| 5 Years | 45.90 | 57.50 | 25.92 | 38.35 | 2,131,072 | -17.74 | -38.65% |
Royalty Pharma Description
| Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. |
